A new IARC live webinar on evidence in primary cancer prevention By Ogkologos - November 11, 2021 478 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR A Combination of Teclistamab and Daratumumab Prolongs PFS in Patients with Relapsed or Refractory Multiple Myeloma Nivolumab Added to Cisplatin and Radiotherapy Improves DFS in Patients with High-Risk Resected Locally Advanced SCCHN EMA Recommends Granting a Marketing Authorisation for Aumolertinib MOST POPULAR Trial Examines Value of Lymph Node Surgery in Advanced Ovarian Cancer March 27, 2019 An existing blood test for ovarian cancer has been re-evaluated. The... October 28, 2020 UK Clinical Trial Compares E-cigarettes, Nicotine-Replacement Products for Smoking Cessation March 8, 2019 Pembrolizumab Plus Chemoradiotherapy Significantly Improves OS in Patients with Locally Advanced... October 11, 2024 Load more HOT NEWS Can Some Women Treated for Endometrial Cancer Forgo Radiation after Surgery? FDA Approves Amivantamab-vmjw with Carboplatin and Pemetrexed for Non-Small Cell Lung... Study Identifies Hundreds of Potential Targets for Cancer Drugs The link between Down syndrome and childhood leukaemia
